C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Clinical trial NCT06868264 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06868264
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2026-09-01
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.